• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[2型糖尿病患者稳定性冠心病的治疗：药物、冠状动脉介入治疗及搭桥手术]

[Treatment of stable coronary artery disease in type II diabetes mellitus: drugs, coronary intervention and bypass surgery].

作者信息

Schneider Christian A, Pfister Roman

机构信息

PAN-Klinik, Köln.

Klinik III für Innere Medizin, Universitätsklinik Köln.

出版信息

Dtsch Med Wochenschr. 2015 Apr;140(9):657-62. doi: 10.1055/s-0041-101941. Epub 2015 Apr 29.

DOI:10.1055/s-0041-101941
PMID:25924045
Abstract

The prognosis of patients with type 2 diabetes is reduced by coronary artery disease. The aim of treatment is therefore not only to treat angina symptoms but also improve the prognosis by medical and interventional treatment. LDL-lowering and coronary revascularisation have the largest beneficial impact on prognosis.

摘要

2型糖尿病患者的预后会因冠状动脉疾病而降低。因此，治疗的目的不仅是治疗心绞痛症状，还要通过药物和介入治疗改善预后。降低低密度脂蛋白和冠状动脉血运重建对预后有最大的有益影响。

相似文献

1
[Treatment of stable coronary artery disease in type II diabetes mellitus: drugs, coronary intervention and bypass surgery].[2型糖尿病患者稳定性冠心病的治疗：药物、冠状动脉介入治疗及搭桥手术]
Dtsch Med Wochenschr. 2015 Apr;140(9):657-62. doi: 10.1055/s-0041-101941. Epub 2015 Apr 29.
2
[The BARI 2D study].[BARI 2D研究]
G Ital Cardiol (Rome). 2010 Oct;11(10):711-7.
3
Coronary revascularization in patients with type 2 diabetes and results of the BARI 2D trial.2型糖尿病患者的冠状动脉血运重建及BARI 2D试验结果
Coron Artery Dis. 2010 May;21(3):189-98. doi: 10.1097/MCA.0b013e3283383ebe.
4
Effects of optimal medical treatment with or without coronary revascularization on angina and subsequent revascularizations in patients with type 2 diabetes mellitus and stable ischemic heart disease.最佳药物治疗联合或不联合冠状动脉血运重建对 2 型糖尿病合并稳定型缺血性心脏病患者心绞痛及后续血运重建的影响。
Circulation. 2011 Apr 12;123(14):1492-500. doi: 10.1161/CIRCULATIONAHA.110.978247. Epub 2011 Mar 28.
5
Advantage of percutaneous coronary intervention over medical therapy in angina relief and the placebo effect.
J Am Coll Cardiol. 2005 Jan 18;45(2):327-8; author reply 328. doi: 10.1016/j.jacc.2004.10.026.
6
Clinical implications of the BARI 2D and COURAGE trials: the evolving role of percutaneous coronary intervention.BARI 2D和COURAGE试验的临床意义：经皮冠状动脉介入治疗的角色演变
Coron Artery Dis. 2010 Nov;21(7):397-401. doi: 10.1097/MCA.0b013e32833d0134.
7
Treatment decisions in stable coronary artery disease: insights from the Euro Heart Survey on Coronary Revascularization.稳定型冠状动脉疾病的治疗决策：来自欧洲冠状动脉血运重建调查的见解
J Thorac Cardiovasc Surg. 2006 Nov;132(5):1001-9. doi: 10.1016/j.jtcvs.2006.05.051.
8
Coronary artery bypass graft surgery (CABG) for patients with diabetes and multivessel coronary artery disease: identifying patients who would benefit with CABG and understanding the potential mechanisms involved.糖尿病合并多支冠状动脉疾病患者的冠状动脉旁路移植术（CABG）：识别将从CABG中获益的患者并了解其中涉及的潜在机制。
Coron Artery Dis. 2010 Nov;21(7):402-6. doi: 10.1097/MCA.0b013e32833bfde3.
9
Ten-year outcomes of patients randomized to surgery, angioplasty, or medical treatment for stable multivessel coronary disease: effect of age in the Medicine, Angioplasty, or Surgery Study II trial.稳定多血管冠状动脉疾病患者随机接受手术、血管成形术或药物治疗的 10 年结果：Medicine, Angioplasty, or Surgery Study II 试验中年龄的影响。
J Thorac Cardiovasc Surg. 2013 Nov;146(5):1105-12. doi: 10.1016/j.jtcvs.2012.08.015. Epub 2012 Aug 31.
10
Do differences in repeat revascularization explain the antianginal benefits of bypass surgery versus percutaneous coronary intervention?: implications for future treatment comparisons.再次血运重建的差异是否解释了搭桥手术与经皮冠状动脉介入治疗相比的抗心绞痛益处？对未来治疗比较的启示。
Circ Cardiovasc Qual Outcomes. 2012 May;5(3):267-75. doi: 10.1161/CIRCOUTCOMES.111.964585. Epub 2012 Apr 10.